Suchergebnisse - (Subject:"Editorial")

PubPharm (27)

1

A Comparison of Genitourinary Society Pathology and International Society of Urological Pathology Prostate Cancer Guidelines

enthalten in: European urology | 2021

von Epstein, J. | Kryvenko, O.

2

The EAU and AUA/CUA/SUFU Guidelines on Recurrent Urinary Tract Infections : What is the Difference?

enthalten in: European urology | 2020

von Naber, K. | Bonkat, G. | Wagenlehner, F.

3

The Complex and Nuanced Care for Early-stage Testicular Cancer : Lessons from the European Association of Urology and American Urological Association Testis Cancer Guidelines

enthalten in: European urology | 2020

von Bagrodia, A. | Pierorazio, P. | Singla, N. | +1

4

Percutaneous suprapubic tube after robotic assisted radical prostatectomy : true or placebo benefit?

enthalten in: European urology | 2014

von Abdollah, F. | Menon, M.

5

The importance of being grade 3 : WHO 1999 versus WHO 2004 pathologic grading

enthalten in: European urology | 2012

von Liedberg, F. | Lauss, M. | Patschan, O. | +11

6

Original Gleason system versus 2005 ISUP modified Gleason system : the importance of indicating which system is used in the patient's pathology and clinical reports

enthalten in: European urology | 2010

von Montironi, R. | Cheng, L. | Lopez-Beltran, A. | +5

CommentIn: Eur Urol. 2011 Mar;59(3):e5-6; author reply e7-8. - PMID 21134713

7

ERSPC and PLCO prostate cancer screening studies : what are the differences?

enthalten in: European urology | 2010

von Schröder, F. | Roobol, M.

8

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?

enthalten in: European urology | 2009

von Dalbagni, G.

CommentOn: Eur Urol. 2009 Aug;56(2):247-56. - PMID 19409692

9

Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer : the debate continues

enthalten in: European urology | 2009

von Sylvester, R.

CommentOn: Eur Urol. 2009 Aug;56(2):260-5. - PMID 19395154

10

Editorial comment on : Cizolirtine citrate, an effective treatment for symptomatic patients with urinary incontinence secondary to overactive bladder: a pilot dose-finding study

enthalten in: European urology | 2009

von May, F. | Bauer, R.

CommentOn: Eur Urol. 2009 Jul;56(1):184-90. - PMID 18485575